Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Glucose/Glycogen Metabolism in Diabetes using MRI
NCT00786825Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Dec 2004
- Primary completion
- Dec 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of somatostatin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by University of Minnesota. Primary endpoint: Brain Glycogen Turnover Rate at 1 month. Started Dec 2004; status: completed.
02
Drugs
somatostatin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00786825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00786825.